| View |
|
DRP-15044
|
Rosuvastatin (as calcium)
|
Lipidbloc
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Healer's Lab (Unit II)
|
India
|
Initial
|
26 March 2024
|
26 March 2029
|
| View |
|
DR-XY49017
|
Febuxostat
|
Febulas 80
|
80 mg
|
Film-Coated Tablet
|
Anti-gout (Preparation Inhibiting Uric Acid Production)
|
Delta Pharma Ltd.
|
Bangladesh
|
Initial
|
26 March 2024
|
26 March 2029
|
| View |
|
DRP-5948-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazomin
|
4 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal (Correction)
|
29 May 2024
|
21 January 2025
|
| View |
|
DR-XY49030
|
Norepinephrine (as bitartrate monohydrate)
|
Nefrinor
|
1 mg/mL (4 mg/4 mL)
|
Solution for Infusion (I.V.)
|
Adrenergic/Dopaminergic Agent.
|
Mefar İlaç Sanayii A.Ş.
|
Turkey
|
Initial
|
27 March 2024
|
27 March 2029
|
| View |
|
DRP-15045
|
Fosfomycin (as trometamol)
|
Exelfos
|
3g
|
Granules For Oral Solution
|
Antibacterial
|
Labiana Pharmaceuticals, SLU
|
Spain
|
Initial
|
27 March 2024
|
27 March 2029
|
| View |
|
DR-XY49025
|
Sterile Water for Injection.
|
none
|
None
|
Sterile Water for Injection
|
Parenteral Diluent
|
Zhejiang Ruixin Pharmaceutical Co. Ltd.
|
China
|
Initial
|
27 March 2024
|
27 March 2029
|
| View |
|
DR-XY49026
|
Ascorbic Acid
|
Asco-C
|
250 mg/mL (500 mg/ 2 mL)
|
Solution for Injection
|
Vitamin
|
Tianjin Kingyork Group Hubei Tianyao Pharmaceutical Co., Ltd.
|
China
|
Initial
|
27 March 2024
|
27 March 2029
|
| View |
|
DRP-12424-03
|
Omeprazole (as sodium monohydrate)
|
Omepace
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
17 March 2024
|
04 August 2027
|
| View |
|
DRP-12424-04
|
Omeprazole (as sodium monohydrate)
|
Briandazole
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
28 March 2024
|
04 August 2027
|
| View |
|
DRP-1272-13
|
Hydrocortisone (as sodium succinate)
|
Aecor-100
|
100 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
07 October 2028
|
| View |
|
DRP-12788-03
|
Omeprazole
|
None
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 March 2024
|
07 October 2027
|
| View |
|
DRP-12864-02
|
Glimepiride
|
Glimegen
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 March 2024
|
18 October 2027
|
| View |
|
DRP-12864-03
|
Glimepiride
|
Retaglim
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
29 March 2024
|
18 October 2027
|
| View |
|
DRP-12879-03
|
Ketoanalogues + Essential Amino Acids
|
Ketosolv
|
630 mg
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
24 March 2024
|
25 October 2027
|
| View |
|
DRP-12914-01
|
Dapagliflozin
|
Glurexa
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug [Sodium-Glucose CoTransporter 2 (SGLT2) Inhibitor]
|
Glenmark Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
13 March 2024
|
28 October 2027
|
| View |
|
DRP-12973-04
|
Ciprofloxacin (as lactate)
|
Goproxacin
|
2 mg/mL (200 mg/100 mL)
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
28 March 2024
|
11 November 2027
|
| View |
|
DRP-13127-05
|
Ketoanalogues + Essential Amino Acids
|
Alqoket
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
05 December 2027
|
| View |
|
DRP-13127-06
|
Ketoanalogues + Essential Amino Acids
|
Ketolove
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
05 December 2027
|
| View |
|
DRP-13171-08
|
Losartan Potassium + Amlodipine (as besilate)
|
Arteva Plus
|
50 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Calcium Channel Blocker (Dihydropyridine derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
14 December 2027
|
| View |
|
DRP-13180-01
|
Multivitamins + Minerals
|
Powercap
|
|
Capsule
|
Multivitamins with Minerals
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
17 March 2024
|
25 September 2027
|